PMC:7199903 / 13291-13530
Annnotations
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T49 | 181-189 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T78 | 235-237 | http://purl.obolibrary.org/obo/CLO_0001000 | denotes | 35 |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T133 | 45-52 | Chemical | denotes | glycans | http://purl.obolibrary.org/obo/CHEBI_18154 |
T134 | 86-95 | Chemical | denotes | immunogen | http://purl.obolibrary.org/obo/CHEBI_60816 |
T135 | 218-225 | Chemical | denotes | glycans | http://purl.obolibrary.org/obo/CHEBI_18154 |
LitCovid-sample-Enju
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T17701 | 0-12 | RB | denotes | Additionally |
T99697 | 12-13 | -COMMA- | denotes | , |
T80820 | 14-17 | DT | denotes | the |
T76134 | 18-28 | NN | denotes | processing |
T62423 | 29-31 | IN | denotes | of |
T20120 | 32-44 | JJ | denotes | complex-type |
T70317 | 45-52 | NNS | denotes | glycans |
T54945 | 53-55 | VBZ | denotes | is |
T38495 | 56-58 | DT | denotes | an |
T67133 | 59-68 | JJ | denotes | important |
T62820 | 69-82 | NN | denotes | consideration |
T6640 | 83-85 | IN | denotes | in |
T89341 | 86-95 | NN | denotes | immunogen |
T16198 | 96-107 | NN | denotes | engineering |
T34295 | 107-108 | -COMMA- | denotes | , |
T17998 | 109-119 | RB | denotes | especially |
T48208 | 120-131 | VBG | denotes | considering |
T59621 | 132-136 | IN | denotes | that |
T38335 | 137-145 | NNS | denotes | epitopes |
T17632 | 146-148 | IN | denotes | of |
T52650 | 149-161 | VBG | denotes | neutralizing |
T94803 | 162-172 | NNS | denotes | antibodies |
T96472 | 173-180 | IN | denotes | against |
T15388 | 181-191 | NN | denotes | SARS-CoV-2 |
T65870 | 192-193 | NN | denotes | S |
T54929 | 194-197 | MD | denotes | can |
T48495 | 198-205 | VB | denotes | contain |
T83428 | 206-217 | VBN | denotes | fucosylated |
T33605 | 218-225 | NNS | denotes | glycans |
T61395 | 226-228 | IN | denotes | at |
T85817 | 229-233 | NN | denotes | N343 |
T96270 | 234-235 | -LRB- | denotes | ( |
T72262 | 235-237 | CD | denotes | 35 |
T73516 | 237-238 | -RRB- | denotes | ) |
R29415 | T54945 | T17701 | arg1Of | is,Additionally |
R61604 | T54945 | T99697 | arg1Of | is,"," |
R11134 | T76134 | T80820 | arg1Of | processing,the |
R58591 | T76134 | T62423 | arg1Of | processing,of |
R53097 | T70317 | T62423 | arg2Of | glycans,of |
R6410 | T70317 | T20120 | arg1Of | glycans,complex-type |
R31957 | T76134 | T54945 | arg1Of | processing,is |
R64311 | T62820 | T54945 | arg2Of | consideration,is |
R92980 | T62820 | T38495 | arg1Of | consideration,an |
R74257 | T62820 | T67133 | arg1Of | consideration,important |
R89401 | T54945 | T6640 | arg1Of | is,in |
R2801 | T16198 | T6640 | arg2Of | engineering,in |
R5066 | T16198 | T89341 | arg1Of | engineering,immunogen |
R63887 | T54945 | T34295 | arg1Of | is,"," |
R45258 | T48208 | T17998 | arg1Of | considering,especially |
R11776 | T76134 | T48208 | arg1Of | processing,considering |
R23707 | T48495 | T48208 | arg2Of | contain,considering |
R3350 | T54945 | T48208 | modOf | is,considering |
R64055 | T48495 | T59621 | arg1Of | contain,that |
R77893 | T38335 | T17632 | arg1Of | epitopes,of |
R80213 | T94803 | T17632 | arg2Of | antibodies,of |
R85241 | T94803 | T52650 | arg1Of | antibodies,neutralizing |
R48071 | T94803 | T96472 | arg1Of | antibodies,against |
R50900 | T65870 | T96472 | arg2Of | S,against |
R11381 | T65870 | T15388 | arg1Of | S,SARS-CoV-2 |
R24221 | T38335 | T54929 | arg1Of | epitopes,can |
R33143 | T48495 | T54929 | arg2Of | contain,can |
R40503 | T38335 | T48495 | arg1Of | epitopes,contain |
R13697 | T33605 | T48495 | arg2Of | glycans,contain |
R22889 | T33605 | T83428 | arg2Of | glycans,fucosylated |
R87734 | T48495 | T61395 | arg1Of | contain,at |
R83302 | T85817 | T61395 | arg2Of | N343,at |
R89433 | T85817 | T96270 | arg1Of | N343,( |
R12740 | T72262 | T96270 | arg2Of | 35,( |
R17492 | T73516 | T96270 | arg3Of | ),( |
LitCovid-sample-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T102 | 45-52 | Chemical | denotes | glycans | http://purl.obolibrary.org/obo/CHEBI_18154 |
T103 | 218-225 | Chemical | denotes | glycans | http://purl.obolibrary.org/obo/CHEBI_18154 |
LitCovid-sample-PD-NCBITaxon
Id | Subject | Object | Predicate | Lexical cue | ncbi_taxonomy_id |
---|---|---|---|---|---|
T53 | 181-191 | Species | denotes | SARS-CoV-2 | NCBItxid:2697049 |
LitCovid-sample-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T88 | 0-239 | Sentence | denotes | Additionally, the processing of complex-type glycans is an important consideration in immunogen engineering, especially considering that epitopes of neutralizing antibodies against SARS-CoV-2 S can contain fucosylated glycans at N343 (35). |
LitCovid-sample-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T43 | 181-191 | Disease | denotes | SARS-CoV-2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-sample-Pubtator
Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
---|---|---|---|---|---|
454 | 192-193 | Gene | denotes | S | Gene:43740568 |
455 | 181-191 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
456 | 45-52 | Chemical | denotes | glycans | MESH:D011134 |
457 | 218-225 | Chemical | denotes | glycans | MESH:D011134 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T88 | 0-239 | Sentence | denotes | Additionally, the processing of complex-type glycans is an important consideration in immunogen engineering, especially considering that epitopes of neutralizing antibodies against SARS-CoV-2 S can contain fucosylated glycans at N343 (35). |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
454 | 192-193 | Gene | denotes | S | Gene:43740568 |
455 | 181-191 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
456 | 45-52 | Chemical | denotes | glycans | MESH:D011134 |
457 | 218-225 | Chemical | denotes | glycans | MESH:D011134 |